Article Information
History
- December 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- A. Wagner1,
- E. Garner-Spitzer1,
- A. Schötta2,
- M. Orola1,
- A. Wessely1,
- I. Zwazl1,
- A. Ohradanova-Repic2,
- G. Tajti2,
- L. Gebetsberger2,
- B. Kratzer3,
- E. Tomosel1,
- M. Kutschera4,
- S. Tobudic5,
- W. F. Pickl3,
- M. Kundi6,
- H. Stockinger2,
- G. Novacek4,
- W. Reinisch4,
- C Zielinski7 and
- U. Wiedermann1,*
- 1Institute of Specific Prophylaxis and Tropical Medicine, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
- 2Institute for Hygiene and Applied Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
- 3Institute of Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria
- 4Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University Vienna, Vienna, Austria
- 5Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria
- 6Center for Public Health, Medical University Vienna, Vienna, Austria
- 7Central European Cancer Center, Wiener Privatklinik, Vienna, Austria, and Central European Cooperative Oncology Group, HQ: Vienna, Austria
- ↵*Corresponding Author:
Prof. Ursula Wiedermann, MD, PhD, Institute of Specific Prophylaxis and Tropical Medicine, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Kinderspitalgasse 15, Vienna A-1090, Austria; email: ursula.wiedermann{at}meduniwien.ac.at
Posted December 14, 2021.
Humoral and cellular immune responses and their kinetics vary in dependence of diagnosis and treatment in immunocompromised patients upon COVID-19 mRNA vaccination
